Enacts requirements for certain reporting regarding the federal 340B drug program

SB 1213 requires certain entities participating in the federal 340B drug program to submit specific reporting data to the state. This bill directly affects hospitals and healthcare providers enrolled in the 340B program, mandating new transparency measures. The legislation focuses solely on establishing reporting obligations without altering the program's core structure or eligibility rules. It is a procedural bill pending its first legislative reading in 2026.